Renal Replacement Knowledge and Preferences for African Americans With Chronic Kidney Disease.

Autor: King A; Department of Nephrology, University of Chicago Medical Center, Chicago, Illinois, USA., Lopez FY; Department of General Internal Medicine, University of Chicago Medical Center, Chicago, Illinois, USA., Lissanu L; Department of General Internal Medicine, University of Chicago Medical Center, Chicago, Illinois, USA., Robinson E; Department of Hospital Medicine, University of Chicago Medical Center, Chicago, Illinois, USA., Almazan E; Department of General Internal Medicine, University of Chicago Medical Center, Chicago, Illinois, USA., Metoyer G; Department of General Internal Medicine, University of Chicago Medical Center, Chicago, Illinois, USA., Tanumihardjo J; Department of General Internal Medicine, University of Chicago Medical Center, Chicago, Illinois, USA., Quinn M; Department of General Internal Medicine, University of Chicago Medical Center, Chicago, Illinois, USA., Peek M; Department of General Internal Medicine, University of Chicago Medical Center, Chicago, Illinois, USA., Saunders M; Department of General Internal Medicine, University of Chicago Medical Center, Chicago, Illinois, USA.
Jazyk: angličtina
Zdroj: Journal of renal care [J Ren Care] 2020 Sep; Vol. 46 (3), pp. 151-160. Date of Electronic Publication: 2020 Jan 09.
DOI: 10.1111/jorc.12312
Abstrakt: Background: Renal replacement therapies (RRT) other than in-centre haemodialyses are underutilised by African Americans with end-stage renal disease (ESRD) even though they are associated with reduced costs, morbidity and mortality as well as improved quality of life for patients.
Objectives: To understand African American patients' knowledge of RRT options and how patient, provider and system-factors contribute to knowledge and preferences. Participants' interviews were conducted at the University of Chicago Medical Center with African American patients with chronic kidney disease (CKD). The final analysis included 28 interviews; 22 patients had CKD not yet on dialysis or having received a transplant, while 6 had reached ESRD and were receiving treatment for kidney failure. Approach Transcripts were uploaded into NVivo8 for coding. Thematic analysis was used for data interpretation.
Results: Four themes were identified: (1) limited knowledge of home modalities and deceased donor options, (2) CKD patients gave little thought to choosing RRT options, (3) CKD patients relied on doctors for treatment decisions, and (4) while patients reported knowledge of living kidney donation transplants (LKDT), it did not translate to receiving an LKDT.
Conclusion: African Americans face significant knowledge and access barriers when deciding on their RRT treatment. Even patients with advanced CKD were still in the early stages of RRT selection. Understanding the knowledge gaps and barriers patients face will inform our subsequent intervention to educate and motivate patients to increase CKD self-care and improve communication between patients, their families and their providers about different RRT treatments.
(© 2020 European Dialysis and Transplant Nurses Association/European Renal Care Association.)
Databáze: MEDLINE
Externí odkaz: